The global healthcare chromatography instrument market size was estimated at USD 1.54 billion in 2023 and is expected to grow at a CAGR of 4.8% from 2024 to 2030. The rising demand from pharmaceutical and biotechnology industries for drug development, quality control, & research and stringent regulatory requirements for drug safety & environmental monitoring compel industries to adopt reliable and precise analytical tools such as chromatography. Moreover, rapid technological advancements, including the development of high-performance and Ultra-High-Performance Liquid Chromatography (UHPLC), enhance the efficiency and accuracy of these instruments, which is expected to propel the market growth.
Chromatography is a vital tool for detecting and quantifying pollutants & contaminants in environmental samples. Environmental testing has become increasingly important, with chromatography techniques being essential for monitoring contaminants in water and air, thus driving the demand for instruments. Growing environmental concerns and the rising need for effective pollutant monitoring significantly drive the demand for chromatography instruments. Environmental agencies and industries are increasingly focused on monitoring air, water, and soil quality to comply with environmental regulations & address public health concerns. As awareness and regulatory scrutiny of environmental issues are growing, the demand for robust chromatographic techniques for environmental testing is expected to continue rising. For instance, in February 2024, Thermo Fisher Scientific introduced the Thermo Scientific Dionex Inuvion Ion Chromatography (IC) system to enhance ion analysis capabilities across various applications. This innovative instrument offers simplified and intuitive operation for laboratories of all scales, enabling efficient analysis of ionic and small polar compounds. With its adaptable design, the Inuvion IC system provides users with a versatile solution, ensuring consistent and dependable results in a single platform.
Stringent regulatory requirements imposed by health and environmental authorities are among the major factors driving the market. Regulatory bodies, such as FDA, European Medicines Agency (EMA), and Environmental Protection Agency (EPA), enforce rigorous standards for drug safety, efficacy, and environmental monitoring. Compliance with these regulations necessitates the use of reliable and precise analytical instruments, such as chromatography systems, to ensure product quality and adherence to safety standards. Consequently, industries are compelled to invest in high-quality chromatographic tools to fulfill these stringent regulatory requirements, driving market growth. The increasing R&D activities in various industries, driven by the expanding application of chromatography techniques, are expected to fuel the growth and adoption of instruments. Rising concerns related to environmental safety, food quality, and forensic testing needs are significantly propelling the market for chromatography technology.
In addition, supportive government initiatives aimed at enhancing R&D, along with increased investments by market players in the pharmaceutical, biotechnology, environmental testing, and food & beverage sectors, are anticipated to impel market growth during the forecast period. For instance, the Horizon 2020 program, a major EU funding initiative for research and innovation, offered substantial grants to advance technologies, including chromatography techniques. This support spans industries like pharmaceutical and environmental sciences, funding projects aimed at enhancing chromatographic analysis and instrument adoption through improved technology & data management.
On the basis of type, the liquid chromatography systems segment held the largest market share of 55.01% in 2023 and is expected to grow at the fastest CAGR over the forecast period owing to its widespread application across various industries, including pharmaceuticals, biotechnology, food & beverage, and environmental testing. Liquid chromatography is favored for its efficiency, accuracy, and ability to separate complex mixtures into individual components, making it indispensable for high-precision analyses and quality control. Innovations such as HPLC and UHPLC enhance the speed, resolution, and sensitivity of analyses, making these systems more appealing to end users.
For instance, in March 2023, Waters Corporation introduced the Alliance iS HPLC System. This system revolutionized QC analyses by simplifying operations and enhancing instrument intelligence, thereby reducing potential errors by up to 40%. Integrated with Waters Empower healthcare chromatography instrument and eConnect HPLC Columns, Alliance iS HPLC enables laboratories to effectively manage operational risks, minimize disruptions, and enhance overall productivity. Its user-friendly touchscreen interface provides real-time system health checks, guided troubleshooting, and maintenance support, empowering analysts to meet critical product release deadlines effortlessly.
Solvents, reagents & adsorbents held the largest market share of 27.75% in 2023 owing to their increasing demand & usage, novel developments, and continuous launch of new products by key players in the market. Moreover, the use of adsorbents is growing due to the availability of materials with improved selectivity and efficiency. The columns segment is expected to grow at the fastest CAGR during the forecast period. Columns are integral components of chromatography systems, essential for the separation and analysis of complex mixtures.
These columns are vital for the purification and analysis of new drug compounds, ensuring compliance with stringent regulatory standards. For instance, in June 2024, Waters Corporation announced that it was the first liquid chromatography column provider to receive My Green Lab ACT Ecolabel Certification for over 40 products in its LC chemistry portfolio. The introduction of innovative column materials and configurations tailored for specific applications, such as reversed-phase, ion exchange, and size exclusion chromatography, also contributes to market growth by offering enhanced performance and versatility.
The healthcare chromatography instrument market in North America dominated the global market and accounted for the largest revenue share of over 44.60% in 2023 owing to the growing biopharmaceutical sector, including the development of biologics & biosimilars, which relies on chromatography for the analysis and purification of complex biological molecules. In addition, the growing digital literacy, development of technologically advanced infrastructure, and the presence of key market players in the region, such as Agilent Technologies, Inc.; Bruker Corporation; Gilson, Inc.; Restek Corporation; Thermo Fisher Scientific, Inc.; and Waters Corporation, are fueling the market growth in the region.
The healthcare chromatography instrument market in the U.S. held the largest market share in 2023. This can be attributed to the growing adoption of technological advancements to revolutionize the healthcare landscape. The rising demand from pharmaceutical and biotechnology sectors for drug development and quality control further fuels market expansion. For instance, in June 2023, Agilent Technologies, Inc. introduced two systems, Agilent 6495D LC/TQ and Revident LC/Q-TOF, along with its latest instrument solutions, Agilent MassHunter Explorer Profiling and Agilent ChemVista library manager. Agilent 6495 LC/TQ system has remarkable sensitivity and intelligent features crucial for facilitating a smooth transition from research to high-volume sample analysis, which enables significant scientific advancements.
The healthcare chromatography instrument market in Europe is expected to grow significantly over the forecast period. The expanding pharmaceutical and biotechnology industries in Europe demand precise analytical tools for drug development, quality control, and regulatory submissions. In addition, increasing research and development activities across various fields, including academia & environmental sciences, contribute to market growth as they require advanced data analysis and management capabilities.
The healthcare chromatography instrument market in Asia Pacific is anticipated to grow at a lucrative CAGR during the forecast period, driven by several key factors. Rapid industrialization and increased research and development activities fuel the demand for chromatography instruments in the pharmaceutical, biotechnology, environmental sciences, and food & beverage industries. Countries such as China, India, & Japan are investing heavily in R&D and infrastructure, enhancing the adoption of these instruments. Moreover, the regulatory landscape in Asia Pacific is becoming more stringent, with authorities emphasizing the need for compliance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards. Regulatory bodies, such as the China FDA, Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and the Central Drugs Standard Control Organization (CDSCO) in India, are enforcing stringent regulations to ensure product safety & efficacy. Healthcare chromatography instruments that offer robust data management, audit trails, and secure data storage are essential for meeting these regulatory requirements.
The market players are focusing on the technological advancement of chromatography products and systems, including automation, for accurate and effective performance. For instance, in June 2021, Water Corporation launched the Waters Arc Premier System, a liquid chromatography system designed to help increase the consistency, speed, and confidence of scientists in deriving analytical results. The growing adoption of advanced technology in research activities for better results & performance and quick access to data, facilitating workflow integration for quick & accurate results and information, is likely to support market growth.
The following are the leading companies in the healthcare chromatography instrument market. These companies collectively hold the largest market share and dictate industry trends.
In April 2024, Waters Corporation introduced the Alliance iS Bio HPLC System, a cutting-edge solution designed to boost efficiency and minimize errors in biopharma quality control laboratories. This advanced system integrates state-of-the-art bioseparation technology with intelligent instrument features, aiming to reduce up to 40% of common errors.
In February 2024, Thermo Fisher Scientific introduced the Dionex Inuvion Ion Chromatography (IC) system, a versatile and user-friendly instrument for ion analysis, offering a comprehensive solution for determining small & ionic polar compounds.
Report Attribute |
Details |
The market size value in 2024 |
USD 1.60 billion |
The revenue forecast in 2030 |
USD 2.11 billion |
Growth rate |
CAGR of 4.8% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD billion & CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, consumable and accessory, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; Mexico; UK; Germany; France; Spain; Italy; Norway; Sweden; Denmark; Japan; China; India; Australia; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Agilent Technologies, Inc.; Waters Corporation; Thermo Fisher Scientific, Inc.; Perkin Elmer; Merck & Co., Inc.; Phenomenex; Bio-Rad Laboratories, Inc.; Cytiva; Hitachi; Restek Corporation; Scion Instruments; SRI Instruments; Gilson, Inc.; Bruker Corporation; Danaher; Shimadzu Corporation. |
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country or regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global healthcare chromatography instrument market report based on type, consumable & accessory, and region:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Liquid Chromatography Systems
High-Performance Liquid Chromatography Systems
Ultra-High-Performance Liquid Chromatography Systems
Medium-Pressure Liquid Chromatography Systems
Flash Chromatography Systems
Others
Gas Chromatography Systems
Supercritical Fluid Chromatography Systems
Thin-Layer Chromatography Systems
Consumable And Accessory Outlook (Revenue, USD Million, 2018 - 2030)
Columns
Pre-packed Columns
Empty Columns
Column Accessories and Consumables
Heaters & Ovens
Guard Holders
Others
Auto samplers
Auto samplers Accessories and Consumables
Autosamplers Syringes
Sample Needles
Vials
Septa
Flow Management Accessories and Consumables
Flowmeters
Flow Splitters
Pumps
Solvents/Reagents/Adsorbents
Chromatography Fittings and Tubing
Tubing
Ferrules and Nuts
Valves and Gauges
Liners and Seals
Detectors
LC Detectors
UV Visible PDA Detectors
Refractive Index Detectors
Fluorescence Detectors
Other LC Detectors
GC Detectors
Flame Ionization Detectors
Mass Spectrometry Detectors
Thermal Conductivity Detectors
Other GC Detectors
Mobile Phase Accessories and Consumables
Mixers and Mixing Chambers
Degassers
Others
Fraction Collectors
Pressure Regulators
Other Accessories and Consumables
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global healthcare chromatography analyzers market size was estimated at USD 1.54 billion in 2023 and is expected to reach USD 1.59 billion in 2024.
b. The global healthcare chromatography analyzers market is expected to grow at a compound annual growth rate of 4.8% from 2024 to 2030 to reach USD 2.11 billion by 2030.
b. North America dominated the healthcare chromatography analyzers market with a share of 44.6% in 2023. This is attributable to presence of large number of pharmaceutical and biopharmaceutical manufacturers in the region
b. Some key players operating in the healthcare chromatography analyzers market include Agilent Technologies, Inc.; Waters Corporation; Thermo Fisher Scientific,Inc.; Perkin Elmer; merck & Co., Inc; Phenomenex; Bio-Rad laboratories, Inc; Hitachi; Restek Corporation; Scion Instruments; SRI Instruments; Gilson, Inc.; Bruker Corporation; Danaher; Shimadzu Corporation
b. Key factors that are driving the market growth include rising demand from the pharmaceutical and biotechnology industries for drug development, quality control, and research.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."